建议为患有慢性肝病的患者接种疫苗
Justyna Janocha-Litwin1,2, Krzysztof Simon1,2
1Department of Infectious Disease and Hepatology, Medical University of Wroclaw, Wroclaw, Poland.
Clinical and experimental hepatology
|April 30, 2025
概括
患有慢性肝病的患者,尤其是肝硬化患者,面临更高的感染风险. 虽然疫苗是安全的,但它们的有效性和吸收受到医生沟通和成本的限制.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 免疫学 免疫学 免疫学
- 公共卫生 公共卫生
背景情况:
- 患有慢性肝病的患者,包括肝硬化,对严重的超级感染的脆弱性增加.
- 这种人群中的感染增加了肝功能衰竭和死亡的风险.
研究的目的:
- 突出疫苗接种在减轻慢性肝病患者感染风险方面的关键作用.
- 为解决这一弱势群体疫苗有效性和实施方面的挑战和局限性.
主要方法:
- 关于慢性肝病患者接种疫苗的现有文献的综述.
- 分析影响疫苗有效性和协议遵守的因素.
- 检查医生沟通和成本障碍的情况.
主要成果:
- 疫苗的安全性通常是确定的,但在患有慢性肝病的个体中,疗效可能受到限制.
- 疫苗接种方案的不充分实施是一个重大问题.
- 医生建议不足和高疫苗成本是关键障碍.
结论:
- 对于患有慢性肝病的患者来说,接种疫苗仍然至关重要,以预防严重的感染.
- 改善医生沟通和解决成本问题对于提高这一群体的疫苗接种率和有效性至关重要.
相关概念视频
Diseases of the Liver and Gallbladder
334
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
334
Esophageal Varices-II: Clinical Features and Management
23
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
23
Vaccinations
43.0K
Overview
43.0K
Transmission-based Precautions I: Contact, Enteric, and Droplets
3.2K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
3.2K
Chronic Pancreatitis II: Collaborative Care
46
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
46
Transmission-based Precautions II: Airborne and Protective Environment
1.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K


